About BioServeBioServe is a leader in the processing, development and validation of diagnostic tests for the practice of personalized, predictive and preventive medicine. Leading pharmaceutical, biotech and diagnostics companies to identify with BioServe cooperation and validate markers that cause disease while correlating clinical and molecular data new diagnostic tests new diagnostic tests, promoting wellness in the world. BioServe provided by the Global Repositor a growing library of over 600,000 human DNA, Tissue and serum samples approved coupled with detailed clinical and demographic data from 140,000 patients from four continents and de – identified.

Until recently, there receives Phase II SBIR To Cervical Cancer Diagnostic commercialization of Arbor Vita Corporation, a biotechnology company, announced today that the National Institutes of Health has been awarded Arbor Vita approximately $ 900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. The Phase II Small Business Innovation Research grant to finance the company test based on the detection of HPV E6 oncoprotein. The E6 as a cancer as a cancer specific marker by HPV, which is associated with the progression of cancer have been identified.‘by courtesy of kaisernetwork.org kaisernetwork.org emphasis You can change the overall Kaiser Daily HIV / AIDS Report, search the archives, and sign up for display email mail delivery. On Kaiser Daily HIV / AIDS report for royal network a free service offered of The Henry J. Kaiser Family Foundation issued 2005 Advisory Board Company and Kaiser Family Foundation, All rights reserved.


Other Posts From Category "medicine":

Related Posts